SONOMA PHARMACEUTICALS, INC. Loans Payable
SONOMA PHARMACEUTICALS, INC. (SNOA) had Loans Payable of $0 as of 2023-03-31, per its 10-K filed 2023-06-21.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LoansPayable · last filed 2023-06-21
- 2023-03-31: Loans Payable $0.00.
- 2022-03-31: Loans Payable $120.00K.
- 2021-03-31: Loans Payable $1.31M.
| Period end | Loans Payable |
|---|---|
| 2023-03-31 | $0.00 10-K · filed 2023-06-21 |
| 2022-03-31 | $120.00K 10-K · filed 2023-06-21 |
| 2021-03-31 | $1.31M 10-K · filed 2022-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |